{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:58:08Z","timestamp":1791849488609,"version":"4.3.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00431-019-03414-8","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T20:19:11Z","timestamp":1561580351000},"page":"1151-1160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hyperinsulinaemic hypoglycaemia\u2014an overview of a complex clinical condition"],"prefix":"10.1007","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-7537","authenticated-orcid":false,"given":"Eirini","family":"Kostopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"3414_CR1","doi-asserted-by":"publisher","first-page":"32983","DOI":"10.3402\/jchimp.v6.32983","volume":"6","author":"ON Ajala","year":"2016","unstructured":"Ajala ON, Huffman DM, Ghobrial II (2016) Glucokinase mutation-a rare cause of recurrent hypoglycemia in adults: a case report and literature review. J Community Hosp Intern Med Perspect 6:32983","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"3414_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1687-9856-2015-S1-P123","volume":"2015","author":"LA Amato","year":"2015","unstructured":"Amato LA, Quigley CA, Neville KA, Hameed S, Verge CF, Woodhead HJ, Walker JL (2015) Sirolimus treatment of severe congenital hyperinsulinism. Int J Pediatr Endocrinol 2015:123","journal-title":"Int J Pediatr Endocrinol"},{"key":"3414_CR3","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1007\/s00259-018-4101-5","volume":"45","author":"K Antwi","year":"2018","unstructured":"Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, Merkle E, Zech CJ, Boll D, Vogt DR, Gloor B, Christ E, Wild D (2018) Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET\/CT, SPECT\/CT and 3T MRI for the localization of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study. Eur J Nucl Med Mol Imaging 45:2318\u20132327","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3414_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1750-1172-6-63","volume":"6","author":"JB Arnoux","year":"2011","unstructured":"Arnoux JB, Verkarre V, Saint-Martin C, Montravers F, Brassier A, Valayannopoulos V, Brunelle F, Fournet JC, Robert JJ, Aigrain Y, Bellann\u00e9-Chantelot C, de Lonlay P (2011) Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis 6:63","journal-title":"Orphanet J Rare Dis"},{"key":"3414_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/312446a0","volume":"312","author":"FM Ashcroft","year":"1984","unstructured":"Ashcroft FM, Harrison DE, Ashcroft SJ (1984) Glucose induces closure of single potassium channels in isolated rat pancreatic \u03b2-cells. Nature 312:446\u2013448","journal-title":"Nature"},{"key":"3414_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fendo.2013.00060","volume":"4","author":"HB Avatapalle","year":"2013","unstructured":"Avatapalle HB, Banerjee I, Shah S, Pryce M, Nicholson J, Rigby L, Caine L, Didi M, Skae M, Ehtisham S et al (2013) Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism. Front Endocrinol (Lausanne) 4:60","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3414_CR7","doi-asserted-by":"publisher","first-page":"F98","DOI":"10.1136\/fn.82.2.F98","volume":"82","author":"A Aynsley-Green","year":"2000","unstructured":"Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-F\u00e9k\u00e9t\u00e9 C, De Lonlay-Debeney P, Brunelle F, Otonkoski T, Thornton P, Lindley KJ (2000) Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 82:F98\u2013F107","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"3414_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/cen.12153","volume":"78","author":"I Banerjee","year":"2013","unstructured":"Banerjee I, Avatapalle B, Padidela R, Stevens A, Cosgrove K, Clayton P, Dunne M (2013) Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism. Clin Endocrinol 78:803\u2013813","journal-title":"Clin Endocrinol"},{"key":"3414_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1515\/JPEM.1999.12.6.873","volume":"12","author":"F Ba\u015f","year":"1999","unstructured":"Ba\u015f F, Darendeliler F, Demirkol D, Bundak R, Saka N, G\u00fcn\u00f6z H (1999) Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab 12:873\u2013878","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3414_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc11-1296","volume":"35","author":"J Beltrand","year":"2012","unstructured":"Beltrand J, Caquard M, Arnoux J-B, Laborde K, Velho G, Verkarre V, Rahier J, Brunelle F, Nihoul-Fekete C, Saudubray JM, Robert JJ, de Lonlay P (2012) Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care 35:198\u2013203","journal-title":"Diabetes Care"},{"key":"3414_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11307-012-0572-0","volume":"15","author":"BA Blomberg","year":"2013","unstructured":"Blomberg BA, Moghbel MC, Saboury B, Stanley CA, Alavi A (2013) The value of radiologic interventions and 18F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol 15:97\u2013105","journal-title":"Mol Imaging Biol"},{"key":"3414_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/00008480-199008000-00024","volume":"2","author":"GJ Bruninig","year":"1990","unstructured":"Bruninig GJ (1990) Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr 2:758\u2013765","journal-title":"Curr Opin Pediatr"},{"key":"3414_CR13","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.2337\/db12-0166","volume":"61","author":"AC Calabria","year":"2012","unstructured":"Calabria AC, Li C, Gallagher PR, Stanley CA, De Le\u00f3n DD (2012) GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel. Diabetes 61:2585\u20132591","journal-title":"Diabetes"},{"key":"3414_CR14","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1073\/pnas.051499698","volume":"98","author":"EA Cartier","year":"2001","unstructured":"Cartier EA, Conti LR, Vandenberg CA, Shyng SL (2001) Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. PNAS 98:2882\u20132887","journal-title":"PNAS"},{"key":"3414_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/EJE-08-0203","volume":"159","author":"HB Christesen","year":"2008","unstructured":"Christesen HB, Tribble ND, Molven A, Siddiqui J, Sandal T, Brusgaard K, Ellard S, Njolstad PR, Alm J, Brock Jacobsen B et al (2008) Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation. Eur J Endocrinol 159:27\u201334","journal-title":"Eur J Endocrinol"},{"key":"3414_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ajmg.10463","volume":"111","author":"P de Lonlay","year":"2002","unstructured":"de Lonlay P, Cornier-Daire V, Amiel J, Touati G, Goldenberg A, Fournet JC, Brunelle F, Nihoul-Fekete C, Rahier J, Junien C, Robert JJ, Saudubreay JM (2002) Facial appearance in persistent hyperinsulinemic hypoglycaemia. Am J Med Genet 111:130\u2013133","journal-title":"Am J Med Genet"},{"key":"3414_CR17","first-page":"84","volume":"3","author":"M Dehdashtian","year":"2014","unstructured":"Dehdashtian M (2014) Reversible pulmonary hypertension in an infant treated with diazoxide. APJMT 3:84\u201386","journal-title":"APJMT"},{"key":"3414_CR18","first-page":"69","volume":"9","author":"H Demirbilek","year":"2017","unstructured":"Demirbilek H, Hussain K (2017) Congenital hyperinsulinism: diagnosis and treatment update. J Clin Res Pediatr Endocrinol 9:69\u201387","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"3414_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1056\/NEJM199703063361005","volume":"336","author":"MJ Dunne","year":"1997","unstructured":"Dunne MJ, Kane C, Shepherd RM, Sanchez JA, James RF, Johnson PR, Aynsley- Green A, Lu S, Clement JP IV, Lindley KJ et al (1997) Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 336:703\u2013706","journal-title":"N Engl J Med"},{"key":"3414_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4274\/jcrpe.1230","volume":"6","author":"E Durmaz","year":"2014","unstructured":"Durmaz E, Flanagan SE, Parlak M, Ellard S, Akcurin S, Bircan I (2014) A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant. J Clin Res Pediatr Endocrinol 6:119\u2013121","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"3414_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s004310051049","volume":"158","author":"D Eichmann","year":"1999","unstructured":"Eichmann D, Hufnagel M, Quick P, Santer R (1999) Treatment of hyperinsulinaemic hypoglycaemia with nifedipine. Eur J Pediatr 158:204\u2013206","journal-title":"Eur J Pediatr"},{"key":"3414_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/j.sempedsurg.2010.10.004","volume":"20","author":"SE Flanagan","year":"2011","unstructured":"Flanagan SE, Kapoor RR, Hussain K (2011) Genetics of congenital hyperinsulinemic hypoglycemia. Semin Pediatr Surg 20:13\u201317","journal-title":"Semin Pediatr Surg"},{"key":"3414_CR23","first-page":"30","volume":"59","author":"JC Fournet","year":"2003","unstructured":"Fournet JC, Junien C (2003) The genetics of neonatal hyperinsulinism. Horm Res 59:30\u201334","journal-title":"Horm Res"},{"key":"3414_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0022-3476(05)80970-9","volume":"123","author":"B Glaser","year":"1993","unstructured":"Glaser B, Hirsch HJ, Landau H (1993) Persistent hyper-insulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr 123:644\u2013650","journal-title":"J Pediatr"},{"key":"3414_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/fn.82.2.F79","volume":"82","author":"B Glaser","year":"2000","unstructured":"Glaser B, Thornton PS, Otonkoski T, Junien C (2000) The genetics of neonatal hyperinsulinism. Arch Dis Child 82:79\u201386","journal-title":"Arch Dis Child"},{"key":"3414_CR26","doi-asserted-by":"crossref","unstructured":"Gregory LC, Ferreira CB, Young-Baird SK, Williams HJ, Harakalova M, van Haaften G, Rahman SA, Gaston-Massuet C, Kelberman D, GOSgene, Qasim W, Camper SA, Dever TE, Shah P, Iain C.A.F., Robinson ICAF, Dattani MT (2019) Impaired EIF2S3 function associated with a novel phenotype of X-linked hypopituitarism with glucose dysregulation. EBioMedicine 42:470\u2013480","DOI":"10.1016\/j.ebiom.2019.03.013"},{"key":"3414_CR27","first-page":"822","volume":"102","author":"M G\u00fcemes","year":"2017","unstructured":"G\u00fcemes M, Shah P, Silvera S, Morgan K, Gilbert C, Hinchey L, Hussain K (2017) Assessment of nifedipine therapy in hyperinsulinemic hypoglycemia due to mutations in the ABCC8 gene. J Clin Endocrinol Metab 102:822\u2013830","journal-title":"J Clin Endocrinol Metab"},{"key":"3414_CR28","first-page":"345","volume":"102","author":"A Gutgold","year":"2017","unstructured":"Gutgold A, Gutgold DJ, Glaser B, Szalat A (2017) Diagnosis of ABCC8 congenital hyperinsulinism of infancy in a 20-year-old man evaluated for factitious hypoglycemia. J Clin Endocrinol Metab 102:345\u2013349","journal-title":"J Clin Endocrinol Metab"},{"key":"3414_CR29","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1210\/jc.2018-01613","volume":"103","author":"A Herrera","year":"2018","unstructured":"Herrera A, Vajravelu ME, Givler S, Mitteer L, Avitabile CM, Lord K, De Leon DD (2018) Prevalence of adverse events in children with congenital hyperinsulinism treated with diazoxide. JCEM 103:4365\u20134372","journal-title":"JCEM"},{"key":"3414_CR30","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S1357-2725(03)00103-1","volume":"35","author":"K Hussain","year":"2003","unstructured":"Hussain K, Aynsley-Green A (2003) Hyperinsulinism in infancy: understanding the pathophysiology. Int J Biochem Cell Biol 35:1312\u20131317","journal-title":"Int J Biochem Cell Biol"},{"key":"3414_CR31","first-page":"203","volume":"17","author":"K Hussain","year":"2004","unstructured":"Hussain K, Thornton PS, Otonkoski T, Aynsley-Green A (2004) Severe transient neonatal hyperinsulinism associated with hyperlactataemia in non-asphyxiated infants. J Pediatr Endocrinol Metab 17:203\u2013209","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3414_CR32","first-page":"163","volume":"2","author":"K Hussain","year":"2004","unstructured":"Hussain K, Aynsley-Green A, Stanley CA (2004) Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI). Pediatr Endocrinol Rev 2:163\u2013167","journal-title":"Pediatr Endocrinol Rev"},{"key":"3414_CR33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jpeds.2005.01.032","volume":"146","author":"K Hussain","year":"2005","unstructured":"Hussain K, Clayton PT, Krywawych S, Chatziandreou I, Mills P, Ginbey DW, Geboers AJ, Berger R, van den Berg IE, Eaton S (2005) Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene. J Pediatr 146:706\u2013708","journal-title":"J Pediatr"},{"key":"3414_CR34","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1126\/science.270.5239.1166","volume":"270","author":"N Inagaki","year":"1995","unstructured":"Inagaki N, Gonoi T, Clement JP 4th, Namba N, Inazawa J, Gonzalez G, Aguilar- Bryan L, Seino S, Bryan J (1995) Reconstitution of KATP: an inward rectifier subunit plus the sulphonylurea receptor. Science 270:1166\u20131170","journal-title":"Science"},{"key":"3414_CR35","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm1296-1344","volume":"2","author":"C Kane","year":"1996","unstructured":"Kane C, Shepherd RM, Squires PE, Johnson PR, James RF, Milla PJ, Aynsley-Green A, Lindley KJ, Dune MJ (1996) Loss of functional KATP channels in pancreatic \u03b2-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med 2:1344\u20131347","journal-title":"Nat Med"},{"key":"3414_CR36","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2337\/db07-1657","volume":"57","author":"RR Kapoor","year":"2008","unstructured":"Kapoor RR, Locke J, Colclough K, Wales J, Conn JJ, Hattersley AT, Ellard S, Hussain K (2008) Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes 57:1659\u20131663","journal-title":"Diabetes"},{"key":"3414_CR37","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1210\/jc.2009-0423","volume":"94","author":"RR Kapoor","year":"2009","unstructured":"Kapoor RR, James C, Flanagan SE, Ellard S, Eaton S, Hussain K (2009) 3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyper-insulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity. JCEM 94:2221\u20132225","journal-title":"JCEM"},{"key":"3414_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/adc.2008.148171","volume":"94","author":"RR Kapoor","year":"2009","unstructured":"Kapoor RR, Flanagan SE, James C, Shield J, Ellard S, Hussain K (2009) Hyperinsulinaemic hypoglycaemia. Arch Dis Child 94:450\u2013457","journal-title":"Arch Dis Child"},{"key":"3414_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4274\/jcrpe.1978","volume":"7","author":"P Khawash","year":"2015","unstructured":"Khawash P, Hussain K, Flanagan SE, Chatterjee S, Basak D (2015) Nifedipine in congenital Hyperinsulinism - a case report. J Clin Res Pediatr Endocrinol 7:151\u2013154","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"3414_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jpedsurg.2012.11.025","volume":"48","author":"P Laje","year":"2013","unstructured":"Laje P, States LJ, Zhuang H, Becker SA, Palladino AA, Stanley CA, Adzick NC (2013) Accuracy of PET\/CT scan in the diagnosis of the focal form of congenital hyperinsulinism. J Pediatr Surg 48:388\u2013393","journal-title":"J Pediatr Surg"},{"key":"3414_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1530\/EJE-11-0874","volume":"166","author":"KH Le Quan Sang","year":"2012","unstructured":"Le Quan Sang KH, Arnoux JB, mamoune A, Saint-Martin C, Bellanne-Chantelot C, Valayannopoulos V, Brassier A, Kayirangwa H, Barbier V, Broissand C, Fabreguettes JR, Charron B, Thalabard JC, de Lonlay P (2012) Successful treatment of congenital hyperinsulinism with long-acting release octreotide. Eur J Endocrinol 166:333\u2013339","journal-title":"Eur J Endocrinol"},{"key":"3414_CR42","doi-asserted-by":"publisher","first-page":"31806","DOI":"10.1074\/jbc.M110.123638","volume":"285","author":"C Li","year":"2010","unstructured":"Li C, Chen P, Palladino A, Narayan S, Russell LK, Sayed S, Xiong G, Chen J, Stokes D, Butt YM, Jones PM, Collins HW, Cohen NA, Cohen AS, Nissim I, Smith TJ, Strauss AW, Matschinsky FM, Bennett MJ, Stanley CA (2010) Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem 285:31806\u201331818","journal-title":"J Biol Chem"},{"key":"3414_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1687-9856-2013-3","volume":"2013","author":"K Lord","year":"2013","unstructured":"Lord K, De Le\u00f3n DD (2013) Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management. Int J Pediatr Endocrinol 2013:3","journal-title":"Int J Pediatr Endocrinol"},{"key":"3414_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000481774","volume":"89","author":"A Ludwig","year":"2018","unstructured":"Ludwig A, Enke S, Heindorf J, Empting S, Meissner T, Mohnike K (2018) Formal neurocognitive testing in 60 patients with congenital hyperinsulinism. Horm Res Paediatr 89:1\u20136","journal-title":"Horm Res Paediatr"},{"key":"3414_CR45","doi-asserted-by":"publisher","first-page":"41184","DOI":"10.1074\/jbc.M006503200","volume":"275","author":"M Matsuo","year":"2000","unstructured":"Matsuo M, Trapp S, Tanizawa Y, Kioka N, Amachi T, Oka Y, Ashcroft FM, Ueda K (2000) Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy. J Biol Chem 275:41184\u201341191","journal-title":"J Biol Chem"},{"key":"3414_CR46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-07-0445","volume":"157","author":"K Mazor-Aronovitch","year":"2007","unstructured":"Mazor-Aronovitch K, Gillis D, Lobel D, Hirsch HJ, Pinhas-Hamiel O, Modan-Moses D, Glaser B, Landau H (2007) Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. Eur J Endocrinol 157:491\u2013497","journal-title":"Eur J Endocrinol"},{"key":"3414_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000129680","volume":"70","author":"K Mohnike","year":"2008","unstructured":"Mohnike K, Blankenstein O, Pfuetzner A, Potzsch S, Schober E, Steiner S, Hardy OT, Grimberg A, van Waarde WM (2008) Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon. Horm Res 70:59\u201364","journal-title":"Horm Res"},{"key":"3414_CR48","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2337\/diab.46.11.1743","volume":"46","author":"A Nestorowicz","year":"1997","unstructured":"Nestorowicz A, Inagaki N, Gonoi T, Schoor KP, Wilson BA, Glaser B, Landau H, Stanley CA, Thornton PS, Seino S, Permutt MA (1997) A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 46:1743\u20131748","journal-title":"Diabetes"},{"key":"3414_CR49","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1515\/jpem-2013-0115","volume":"26","author":"OM Neylon","year":"2013","unstructured":"Neylon OM, Moran MM, Pellicano A, Nightingale M, O\u2019Connell MA (2013) Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism. J Pediatr Endocrinol Metab 26:1157\u20131161","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3414_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2337\/diabetes.52.1.199","volume":"52","author":"T Otonkoski","year":"2003","unstructured":"Otonkoski T, Kaminen N, Ustinov J, Lapatto R, Meissner T, Mayatepek E, Kere J, Sipila I (2003) Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. Diabetes 52:199\u2013204","journal-title":"Diabetes"},{"key":"3414_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2337\/diabetes.55.01.06.db05-1128","volume":"55","author":"T Otonkoski","year":"2006","unstructured":"Otonkoski T, N\u00e4nt\u00f6-Salonen K, Sepp\u00e4nen M, Veijola R, Huopio H, Hussain K, Tapanainen P, Eskola O, Parkkola R, Ekstrom K et al (2006) Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes 55:13\u201318","journal-title":"Diabetes"},{"key":"3414_CR52","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1086\/520960","volume":"81","author":"T Otonkoski","year":"2007","unstructured":"Otonkoski T, Jiao H, Kaminen-Ahola N, Tapia-Paez I, Ullah MS, Parton LE, Schuit F, Quintens R, Sipila I, Mayatepek E et al (2007) Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic \u03b2 cells. Am J Hum Genet 81:467\u2013474","journal-title":"Am J Hum Genet"},{"key":"3414_CR53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1373\/clinchem.2007.098988","volume":"54","author":"AA Palladino","year":"2008","unstructured":"Palladino AA, Bennett MJ, Stanley CA (2008) Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Clin Chem 54:256\u2013263","journal-title":"Clin Chem"},{"key":"3414_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1517\/14740338.2013.752814","volume":"12","author":"N Pallet","year":"2013","unstructured":"Pallet N, Legendre C (2013) Adverse events associated with mTOR inhibitors. Expert Opin Drug Saf 12:177\u2013186","journal-title":"Expert Opin Drug Saf"},{"key":"3414_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.sempedsurg.2010.10.009","volume":"20","author":"A Pierro","year":"2011","unstructured":"Pierro A, Nah SA (2011) Surgical management of congenital hyperinsulinism of infancy. Semin Pediatr Surg 20:50\u201353","journal-title":"Semin Pediatr Surg"},{"key":"3414_CR56","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1172\/JCI35414","volume":"118","author":"SE Pinney","year":"2008","unstructured":"Pinney SE, MacMullen C, Becker S, Lin YW, Hanna C, Thornton P, Ganguly A, Shyng SL, Stanley CA (2008) Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest 118:2877\u20132886","journal-title":"J Clin Invest"},{"key":"3414_CR57","doi-asserted-by":"publisher","first-page":"F108","DOI":"10.1136\/fn.82.2.F108","volume":"82","author":"J Rahier","year":"2000","unstructured":"Rahier J, Guiot Y, Sempoux C (2000) Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed 82:F108\u2013F112","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"3414_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1530\/JME-15-0016","volume":"54","author":"SA Rahman","year":"2015","unstructured":"Rahman SA, Nessa A, Hussain K (2015) Molecular mechanisms of congenital hyperinsulinism. J Mol Endocrinol 54:119\u2013129","journal-title":"J Mol Endocrinol"},{"key":"3414_CR59","unstructured":"Rico-Bautista E, Kusnetzow AK, Fowler \u039c\u0391, Athanacio J, Kredel TA, Zhao J, Wang S, Markinson S, Fei Zhu Y, Struthers RS, Betz SF, Crinetics Pharmaceuticals, San Diego, CA (2019) Selective nonpeptide somatostatin receptor subtype 5 (sst5) agonists suppress induced insulin secretion in pancreatic islets from both rats and healthy human donors. Presented in Endo 2019"},{"key":"3414_CR60","doi-asserted-by":"publisher","first-page":"E1540","DOI":"10.1210\/jc.2015-2763","volume":"100","author":"K Rozenkova","year":"2015","unstructured":"Rozenkova K, Malikova J, Nessa A, Dusatkova L, Bj\u00f8rkhaug L, Obermannova B, Dusatkova P, Kytnarova J, Aukrust I, Najmi LA, Rypackova B, Sumnik Z, Lebl J, Nj\u00f8lstad PR, Hussain K, Pruhova S (2015) High incidence of heterozygous ABCC8 and HNF1A mutations in Czech patients with congenital hyperinsulinism. J Clin Endocrinol Metab 100:E1540\u2013E1549","journal-title":"J Clin Endocrinol Metab"},{"key":"3414_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/pedi.12548","volume":"19","author":"A Sakakibara","year":"2018","unstructured":"Sakakibara A, Hashimoto Y, Kawakita R, Hosokawa Y, Nagahara K, Hasegawa Y, Hoshino S, Nagasaka H, Yorifuji T (2018) Diagnosis of congenital hyperinsulinism: biochemical profiles during hypoglycaemia. Pediatr Diabetes 19:259\u2013264","journal-title":"Pediatr Diabetes"},{"key":"3414_CR62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-016-0547-3","volume":"11","author":"M Salomon-Estebanez","year":"2016","unstructured":"Salomon-Estebanez M, Flanagan SE, Ellard S, Rigby L, Bowden L, Mohamed Z, Nicholson J, Skae M, Hall C, Craigie R, Padidela R, Murphy N, Randell T, Cosgrove KE, Dunne MJ, Banerjee I (2016) Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time. Orphanet J Rare Dis 11:163","journal-title":"Orphanet J Rare Dis"},{"key":"3414_CR63","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2337\/db08-1792","volume":"58","author":"S Sayed","year":"2009","unstructured":"Sayed S, Langdon DR, Odili S, Chen P, Buettger C, Schiffman AB, Suchi M, Taub R, Grimsby J, Matschinsky FM, Stanley CA (2009) Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations. Diabetes 58:1419\u20131427","journal-title":"Diabetes"},{"key":"3414_CR64","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMoa1310967","volume":"370","author":"S Senniappan","year":"2014","unstructured":"Senniappan S, Alexandrescu S, Tatevian N, Shah P, Arya V, Flanagan S, Ellard S, Rampling D, Ashworth M, Brown R et al (2014) Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia. N Engl J Med 370:1131\u20131137","journal-title":"N Engl J Med"},{"key":"3414_CR65","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000439131","volume":"84","author":"P Shah","year":"2015","unstructured":"Shah P, Rahman SA, McElroy S, Gilbert C, Morgan K, Hinchey L, Senniappan S, Levy H, Amin R, Hussain K (2015) Use of long-acting Somatostatin analogue (Lanreotide) in an adolescent with Diazoxide-responsive congenital Hyperinsulinism and its psychological impact. Horm Res Paediatr 84:355\u2013360","journal-title":"Horm Res Paediatr"},{"key":"3414_CR66","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S2213-8587(16)30323-0","volume":"5","author":"P Shah","year":"2016","unstructured":"Shah P, Rahman SA, Demirbilek H, G\u00fcemes M, Hussain K (2016) Hyperinsulinaemic hypoglycaemia in children and adults. Lancet Diabetes Endocrinol 5:729\u2013742","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3414_CR67","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF02734240","volume":"69","author":"P Shanbag","year":"2002","unstructured":"Shanbag P, Pathak A, Vaidya M, Shahid SK (2002) Persistent hyperinsulinemic hypoglycemia of infancy-successful therapy with nifedipine. Indian J Pediatr 69:271\u2013272","journal-title":"Indian J Pediatr"},{"key":"3414_CR68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fendo.2014.00031","volume":"5","author":"M Skae","year":"2014","unstructured":"Skae M, Avatapalle HB, Banerjee I, Rigby L, Vail A, Foster P, Charalambous C, Bowden L, Padidela R, Patel L, Ehthsham S, Cosgrove KE, Dunne MJ, Clayton P (2014) Reduced glycemic variability in diazoxide-responsive children with congenital hyperinsulinism using supplemental omega-3-polyunsaturated fatty acids; a pilot trial with MaxEPAR. Front Endocrinol 5:31","journal-title":"Front Endocrinol"},{"key":"3414_CR69","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.ymgme.2003.10.013","volume":"81","author":"CA Stanley","year":"2004","unstructured":"Stanley CA (2004) Hyperinsulinism\/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. Mol Genet Metab 81:S45\u2013S51","journal-title":"Mol Genet Metab"},{"key":"3414_CR70","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1210\/jc.2015-3651","volume":"101","author":"CA Stanley","year":"2016","unstructured":"Stanley CA (2016) Perspective on the genetics and diagnosis of congenital hyperinsulinism disorders. JCEM 101:815\u2013826","journal-title":"JCEM"},{"key":"3414_CR71","first-page":"S39","volume":"82","author":"C Suprasongsin","year":"1999","unstructured":"Suprasongsin C, Suthutvoravut U, Mahachoklertwattana P, Preeyasombat C (1999) Combined raw cornstarch and nifedipine as an additional treatment in persistent hyperinsulinemic hypoglycemia of infancy. J Med Assoc Thail 82:S39\u2013S42","journal-title":"J Med Assoc Thail"},{"key":"3414_CR72","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1210\/jc.2016-2711","volume":"101","author":"M Szymanowski","year":"2016","unstructured":"Szymanowski M, Estebanez MS, Padidela R, Han B, Mosinska K, Stevens A, Damaj L, Pihan-Le Bars F, Lascouts E, Reynaud R et al (2016) mTOR inhibitors for the treatment of severe congenital hyperinsulinism: perspectives on limited therapeutic success. J Clin Endocrinol Metab 101:4719\u20134729","journal-title":"J Clin Endocrinol Metab"},{"key":"3414_CR73","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1126\/science.7716548","volume":"268","author":"PM Thomas","year":"1995","unstructured":"Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J (1995) Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268:426\u2013429","journal-title":"Science"},{"key":"3414_CR74","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/hmg\/5.11.1809","volume":"5","author":"P Thomas","year":"1996","unstructured":"Thomas P, Ye Y, Lightner E (1996) Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 5:1809\u20131812","journal-title":"Hum Mol Genet"},{"key":"3414_CR75","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0022-3476(05)80969-2","volume":"123","author":"PS Thornton","year":"1993","unstructured":"Thornton PS, Alter CA, Katz LE, Baker L, Stanley CA (1993) Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr 123:637\u2013643","journal-title":"J Pediatr"},{"key":"3414_CR76","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00246-017-1652-3","volume":"38","author":"MR Timlin","year":"2017","unstructured":"Timlin MR, Black AB, Delaney HM, Matos RI, Percival CS (2017) Development of pulmonary hypertension during treatment with diazoxide: a case series and literature review. Pediatr Cardiol 38:1247\u20131250","journal-title":"Pediatr Cardiol"},{"key":"3414_CR77","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1369\/jhc.2008.951319","volume":"56","author":"D Tornehave","year":"2008","unstructured":"Tornehave D, Kristensen P, Rorner J, Knudsen LB, Heller RS (2008) Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem 56:841\u2013851","journal-title":"J Histochem Cytochem"},{"key":"3414_CR78","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1172\/JCI4495","volume":"102","author":"V Verkarre","year":"1998","unstructured":"Verkarre V, Fournet JC, de Lonlay P, Gross-Morand MS, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM et al (1998) Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 102:1286\u20131291","journal-title":"J Clin Invest"},{"key":"3414_CR79","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-015-0367-x","volume":"10","author":"A Welters","year":"2015","unstructured":"Welters A, Lerch C, Kummer S, Marquard J, Salgin B, Mayatepek E, Meissner T (2015) Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers. Orphanet J Rare Dis 10:150","journal-title":"Orphanet J Rare Dis"},{"key":"3414_CR80","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13023-018-0970-8","volume":"13","author":"A Welters","year":"2017","unstructured":"Welters A, Meissner T, Grulich-Henn J, Frohlich-Reiterer E, Warncke K, Mohnike K, Blankenstein O, Menzel U, Datz N, Bollow E, Holl RW (2017) Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism. Orphanet J Rare Dis 13:230","journal-title":"Orphanet J Rare Dis"},{"key":"3414_CR81","doi-asserted-by":"publisher","first-page":"30697","DOI":"10.1074\/jbc.M505553200","volume":"280","author":"S Wullschleger","year":"2005","unstructured":"Wullschleger S, Loewith R, Oppliger W, Hall MN (2005) Molecular organization of target of rapamycin complex 2. J Biol Chem 280:30697\u201330704","journal-title":"J Biol Chem"},{"key":"3414_CR82","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00109-011-0834-3","volume":"90","author":"SB Yang","year":"2012","unstructured":"Yang SB, Lee HY, Rapamycin DM, Tien AC, Rowson-Baldwin A, Shu YY, Jan YN, Jan LY (2012) Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity. J Mol Med (Berl) 90:575\u2013585","journal-title":"J Mol Med (Berl)"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-019-03414-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-019-03414-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-019-03414-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T23:16:44Z","timestamp":1593040604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-019-03414-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3414"],"URL":"https:\/\/doi.org\/10.1007\/s00431-019-03414-8","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"assertion":[{"value":"22 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}